Comparative Benchmarking
In the context of the broader market, PHAR competes directly with industry leaders such as ORIC and AMPH. With a market capitalization of $1.44B, it holds a leading position in the sector. When comparing efficiency, PHAR's gross margin of N/A stands against ORIC's N/A and AMPH's 51.42%. Such benchmarking helps identify whether Pharming Group NV is trading at a premium or discount relative to its financial performance.
